Comments
Loading...

ZyVersa Therapeutics

ZVSANASDAQ
Logo brought to you by Benzinga Data
$1.14
-0.01-0.87%
At close: -
$1.11
-0.03-2.63%
After Hours: 7:41 PM EDT

ZyVersa Therapeutics (NASDAQ:ZVSA) Stock, Earnings Estimates, EPS, And Revenue

ZyVersa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-2.430
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of ZyVersa Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

ZyVersa Therapeutics (ZVSA) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-14$-2.43$-3.7034.3 %
Jun 20242024-08-09$-3.31$-3.7511.7 %
Mar 20242024-05-15$-4.53$-3.70-22.4 %
Dec 20232024-03-25$-0.25$-42.8099.4 %

ZyVersa Therapeutics (ZVSA) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is ZyVersa Therapeutics (NASDAQ:ZVSA) reporting earnings?

A

ZyVersa Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for ZyVersa Therapeutics (NASDAQ:ZVSA)?

A

ZyVersa Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-2.43, which beat the estimate of $-3.70.

Q

What were ZyVersa Therapeutics’s (NASDAQ:ZVSA) revenues?

A

ZyVersa Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch